On this page
Evidence dossier
The report behind the claim
The investigators reported improved healing and functional measures after experimental local or systemic treatment. A crush model is not evidence for bodybuilding, ordinary soreness or a human recovery timeline.
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats with a standardized gastrocnemius-complex crush injury
- Endpoint
- Macroscopic and microscopic healing, function and enzyme activity
- Finding on record
- The investigators reported improved healing and functional measures after experimental local or systemic treatment.
- Limits of inference
- A crush model is not evidence for bodybuilding, ordinary soreness or a human recovery timeline.
The experiment in view
The study used rats with a standardized gastrocnemius-complex crush injury. Its principal measures were macroscopic and microscopic healing, function and enzyme activity. The investigators reported improved healing and functional measures after experimental local or systemic treatment.
Reading the result closely
A crushed muscle differs from a clean transection, a tendon injury and normal exercise-related discomfort. Those distinctions matter even though all may be marketed as recovery. The local cream and systemic experimental routes also need to stay separate when comparing the reported findings with a modern product.
The boundary of the finding
A crush model is not evidence for bodybuilding, ordinary soreness or a human recovery timeline.
Related evidence, kept separate
BPC-157 in a lower-limb reperfusion model examines acute muscle histology, oxidative stress, inflammatory and apoptosis markers. Here, the measured endpoint was macroscopic and microscopic healing, function and enzyme activity. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with The BPC-157 sciatic-nerve paper: keep the surgical model in the claim appraisal.
On the record
The documents supporting this report.